Trials:

1. Bowden CL, et al.; for the Lamictal 606 Study Group. Arch Gen Psychiatry 2003;6:392-400.
2. Bowden C, et al. World J of Biol Psychiatry 2004;5(Suppl 1):48. 
3. Bowden C, et al. Expert Opinion on Investigational Drugs 2004 (In press).
4. Calabrese JR, et al.; for the Lamictal 605 Study Group. J Clin Psychiatry 2003;64:1013-24.
5. Calabrese JR, et al. Am J Psychiatry 1999;156:1019-23.
6. Calabrese JR, et al.; for the Lamictal 614 Study Group. J Clin Psychiatry 2000;61:841-50.
7. Calabrese JR, et al. J Clin Psychiatry 1999;60:79-88.
8. Calabrese PJR, et al. European Neuropsychopharmacology. The Journal of the European College of Neuropsychopharmacology 2003;13(Suppl 4):S265.
9. Calabrese JR, et al. Drug Saf 2004;27:173-84. and J Clin Psychiatry 2002,63:1012-19.
10. Chen C, et al. Br J Clin Pharmacol 2000;50:193-5.
11. McElroy SL, et al. J Clin Psychiatry 2004;65:204-10.
12. Frye MA, et al. Clin Psychopharmacol 2000;20:607-14.
13. Frye M, et al. European Neuropsychopharmacology. The Journal of the European College of Neuropsychopharmacology 2003;13(Suppl 4):S267. 
14. Goodwin GM, et al. J Clin Psychiatry 2004;65:432-41.
15. Grunze H, et al. European Neuropsychopharmacology. The Journal of the European College of Neuropsychopharmacology 2003;13(Suppl 4): S265. 
16. LeadbetterR, et al. Psychiatric Annals 2002;32:766-72.
17. Rapaport M, et al. European Neuropsychopharmacology. The Journal of the European College of Neuropsychopharmacology  2003;13(Suppl 4):S457. 
18. Vieta E, et al. European Neuropsychopharmacology. The Journal of the European College of Neuropsychopharmacology 2003;13(Suppl 4):S265. 
19. Walden J, et al. Bipolar Disord 2000;2:336-9.
20. Wang P, et al. APA 2004, New Research Presentation.
21. Wong ICK,et al. Ann Pharmacother 1999;33:1037-42.
22. Yatham L, et al. European Neuropsychopharmacology. The Journal of the European College of Neuropsychopharmacology 2003;13(Suppl 4):S266.

Reviews:

1. Goldsmith DR, et al. Drugs 2003;63:2029-50.
2. Bowden CL, et al. Drug Saf 2004;27:173-84.
3. Ketter TA and Calabrese JR. J Clin Psychiatry 2002;63:146-51.

• WFSBP:
  Grunze, et al. World J Biol Psychiatry 2003; 4:5-13.
• Danish Guidelines:
  Licht, et al. Acta Psychiatr Scand 2003;108(S419):1-22. 
• Australian Guidelines:
  Mitchell PB, et al. Australasian Psychiatry 11(1):39-53.
• BAP Guidelines:
  Goodwin, et al. J Psychopharmacol 2003;17:149-73.
• APA Guidelines:
  Hirschfeld, et al. Am J Psychiatry 2002;159(4 Suppl):1-50.
• ICG Guidelines:
  J Clin Psychiatry 2004;65:(In press).